June 11 (Reuters) - The weight-loss drug market is booming, with biotech firms racing to capture a slice of a fast-growing ...

The natural GLP-1 hormone survives in the body for only a few minutes before it is broken down. Drug developers overcome this ...

Novo Nordisk’s oral semaglutide 25 mg achieved up to 16.6% weight loss in a landmark study, rivaling injectable Wegovy. The pill also improved cardiovascular risk factors and physical activity levels.

Led by the renowned bariatric surgeon Dr. Amit Taggar, the family-owned practice marks one year of patient-centered, advanced weight loss surgery in Tampa, FL. At TWLI, patients are treated like ...

Novo Nordisk’s experimental weekly shot CagriSema was shown to lead to less dramatic weight loss compared to rival Lilly’s Tirzepatide, the drug behind Zepbound and Mounjaro, in an 84-week trial, Novo ...

Novo Nordisk agreed to collaborate with Replicate Biosciences to develop potential new treatments for obesity, type 2 diabetes and other cardiometabolic diseases, as it grapples with mounting ...

It's not uncommon to see initial success in your weight loss journey, only to hit a plateau later on. To combat this, a popular weight loss coach with a whopping 545,000 followers on TikTok has ...

GLP-1 receptor agonists (GLP-1 RAs) produced meaningful weight loss in patients with cirrhosis. Although those with compensated disease did not face notable muscle loss, those with decompensated ...

HUNTINGTON, W.Va. (WSAZ) - Getting older can bring some extra challenges when it comes to losing weight. Dustin Holston from Advanced Nutrition Solutions stopped by First Look at Four to share how his ...

"Our study showed that a distance-based approach produced similar weight loss to more intensive, in-person interventions, demonstrating that this kind of program could be administered to larger groups ...